Picard Medical Inc PMI
๐ Company Profile
| Industry | Health Care |
| Country | US |
| Exchange | NYSE MKT LLC |
| Currency | USD |
| IPO Date | 2025-08-29 |
| Shares Out. | 102,700,000 |
| Website | picardmedical.com โ |
| Phone | 18003166660 |
| Employees | 75 |
| Revenue | $1.2M |
| Gross Profit | $275,000 |
| Net Income | -$7.6M |
| Free Cash Flow | -$17.0M |
| Total Assets | $11.2M |
| Total Liabilities | $12.7M |
| Equity | -$1.4M |
About Picard Medical Inc
Picard Medical Inc operates through its wholly owned subsidiary, a medical technology company focused on developing, manufacturing, and commercializing the SynCardia TAH, an implantable total artificial heart system. The company is engaged in designing, manufacturing, producing, supplying, marketing, and selling medical device products, including the SynCardia TAH, which is designed to assume the full function of a failed human heart in patients suffering from advanced heart failure. The SynCardia TAH replaces both the left and right ventricles as well as all four heart valves.
Picard Medical Inc is a publicly traded company under the ticker symbol PMI on the NYSE MKT LLC, operating in the Health Care industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
